Wave Life Sciences has lost GSK as the partner for its RNA-editing drug for alpha-1 antitrypsin deficiency (AATD), just over ...

Two months later, the institute launched the Standardized Organoid Modeling Center, a national initiative financed with an initial commitment of $87 million over three years, intended to improve the ...

Both products can be used in the UK to provide protection against RSV disease in certain settings. Abrysvo was cleared for ...

Joenja is a sizeable contributor to Pharming's revenues, accounting for €38 million ($45 million) of its total sales of €70 ...

Venglustat is designed to reduce the toxic build-up, and the new trial showed that a daily dose of the drug achieved ...

Patients in the EU with rare disease thymidine kinase 2 deficiency (TK2d) could be just weeks away from having the first ...

Eli Lilly has revealed the fourth new manufacturing site in its $27 billion capital investment spree in the US – a $3.5 ...

Acute pancreatitis is linked to the development of gallstones, which are listed as a side effect with GLP-1 drugs. Ahmed said ...

As this complexity deepens, a simple truth emerges: classical measurement frameworks cannot keep pace with a system that is no longer linear, nor even merely non-linear, but fundamentally ...

The new announcements bring the number of IPOs priced this week to four, coming shortly after South San Francisco ...

Tenpoint Therapeutics is set to join the US market for drugs to treat presbyopia, taking on rival therapies from AbbVie, ...

On behalf of Lilly, Seamless will design and programme recombinases that can correct alterations in multiple genes involved ...